Structural Biomarkers Influencing Drusenoid Pigment Epithelial Detachment Lifecycle and the Development of Late Macular Degeneration Article Swipe
Serena Fragiotta
,
Giuseppe Querques
,
Maria Sole Polito
,
Eliana Costanzo
,
Tommaso Rossi
,
Monica Varano
,
Francesca Maria Pannarale
,
Yoichi Sakurada
,
Mariacristina Parravano
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.xops.2025.100977
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.xops.2025.100977
Purpose: Drusenoid pigment epithelial detachment (dPED) is a notable phenotype in age-related macular degeneration (AMD), often evolving into macular complications such as macular neovascularization (MNV) and geographic atrophy (GA). The aim of this study was to identify potential prognostic biomarkers associated with the development of both MNV and GA. Design: A retrospective cohort study. Participants: Patients with dPED in the setting of AMD. Methods: This observational study analyzed OCT biomarkers to assess the dPED lifecycle and identify features predictive of macular complications. Seventy-one eyes with dPED from 51 patients were reviewed over an average follow-up of 37.5 ± 17.6 months (range: 24–104), examining structural alterations via multimodal imaging, which included color fundus photography, fundus autofluorescence, and OCT, while fluorescein angiography, indocyanine green angiography, or both were performed as needed. Associations between baseline biomarkers and macular complications were assessed using Cox proportional hazard models with a frailty term to account for intereye correlation. The Fine–Gray model was used to account for competing risk analysis. Main Outcome Measures: Incidence and time to development of macular complications (MNV and GA) and their associations with baseline OCT biomarkers (cuticular drusen, hyperreflective foci, external limiting membrane/ellipsoid zone integrity, and retinal pigment epithelium [RPE] hypertransmission), modeled with frailty-adjusted Cox proportional hazards and Fine–Gray competing risks; secondary measures included dPED lifecycle features (collapse, timing) and morphometrics (height, width, volume). Results: Key findings included a 39.4% incidence of dPED collapse, with 60.7% of cases progressing to complications postcollapse. In the multivariable Cox proportional model, cuticular drusen (hazard ratio [HR]: 3.8, 95% confidence interval [CI]: 1.62–9.2, P = 0.002) and the presence of hyperreflective foci (HRF) at baseline (HR: 6.6, 95% CI: 1.97–22, P = 0.02) represented the main prognostic indicators of macular complications. In the Fine–Gray competing risks analysis, cuticular drusen remained a significant independent predictor (subdistribution hazard ratio [sHR] = 18.1, 95% CI: 1.89–174, P = 0.01) of MNV development, while HRF (sHR = 6.69, 95% CI: 1.98–22.61, P = 0.002) and external limiting membrane disruption at baseline (sHR = 3.69, 95% CI: 1.03–13.14, P = 0.044) were factors significantly associated with increased GA risk. Conclusions: These results underscore the prognostic relevance of specific imaging biomarkers in dPED. Recognizing these features early may support timely treatment and help prevent irreversible photoreceptor and RPE damage. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.xops.2025.100977
- https://www.ophthalmologyscience.org/article/S2666-9145(25)00275-1/pdf
- OA Status
- gold
- References
- 47
- OpenAlex ID
- https://openalex.org/W4415215570
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415215570Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.xops.2025.100977Digital Object Identifier
- Title
-
Structural Biomarkers Influencing Drusenoid Pigment Epithelial Detachment Lifecycle and the Development of Late Macular DegenerationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-15Full publication date if available
- Authors
-
Serena Fragiotta, Giuseppe Querques, Maria Sole Polito, Eliana Costanzo, Tommaso Rossi, Monica Varano, Francesca Maria Pannarale, Yoichi Sakurada, Mariacristina ParravanoList of authors in order
- Landing page
-
https://doi.org/10.1016/j.xops.2025.100977Publisher landing page
- PDF URL
-
https://www.ophthalmologyscience.org/article/S2666-9145(25)00275-1/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.ophthalmologyscience.org/article/S2666-9145(25)00275-1/pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
47Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415215570 |
|---|---|
| doi | https://doi.org/10.1016/j.xops.2025.100977 |
| ids.doi | https://doi.org/10.1016/j.xops.2025.100977 |
| ids.openalex | https://openalex.org/W4415215570 |
| fwci | 0.0 |
| type | article |
| title | Structural Biomarkers Influencing Drusenoid Pigment Epithelial Detachment Lifecycle and the Development of Late Macular Degeneration |
| biblio.issue | 1 |
| biblio.volume | 6 |
| biblio.last_page | 100977 |
| biblio.first_page | 100977 |
| topics[0].id | https://openalex.org/T10170 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Retinal Diseases and Treatments |
| topics[1].id | https://openalex.org/T11438 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9965000152587891 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Retinal Imaging and Analysis |
| topics[2].id | https://openalex.org/T10691 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9932000041007996 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Retinal Development and Disorders |
| is_xpac | False |
| apc_list.value | 2500 |
| apc_list.currency | USD |
| apc_list.value_usd | 2500 |
| apc_paid.value | 2500 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2500 |
| language | en |
| locations[0].id | doi:10.1016/j.xops.2025.100977 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210240620 |
| locations[0].source.issn | 2666-9145 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2666-9145 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Ophthalmology Science |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | https://www.ophthalmologyscience.org/article/S2666-9145(25)00275-1/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Ophthalmology Science |
| locations[0].landing_page_url | https://doi.org/10.1016/j.xops.2025.100977 |
| locations[1].id | pmh:oai:doaj.org/article:cb5981be00274d4fb55ed83763341a20 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].source.host_organization_lineage | |
| locations[1].license | cc-by-sa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Ophthalmology Science, Vol 6, Iss 1, Pp 100977- (2026) |
| locations[1].landing_page_url | https://doaj.org/article/cb5981be00274d4fb55ed83763341a20 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5009105924 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-6214-6270 |
| authorships[0].author.display_name | Serena Fragiotta |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Serena Fragiotta |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5008174671 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3292-9581 |
| authorships[1].author.display_name | Giuseppe Querques |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Giuseppe Querques |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5071601171 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2924-7280 |
| authorships[2].author.display_name | Maria Sole Polito |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Maria Sole Polito |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5057607340 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9916-8895 |
| authorships[3].author.display_name | Eliana Costanzo |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Eliana Costanzo |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5087688544 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-0332-7757 |
| authorships[4].author.display_name | Tommaso Rossi |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Tommaso Rossi |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5012276258 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6530-1563 |
| authorships[5].author.display_name | Monica Varano |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Monica Varano |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5120011540 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Francesca Maria Pannarale |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Francesca Maria Pannarale |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5051073019 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2894-0454 |
| authorships[7].author.display_name | Yoichi Sakurada |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Yoichi Sakurada |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5022647583 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-2223-7311 |
| authorships[8].author.display_name | Mariacristina Parravano |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Mariacristina Parravano |
| authorships[8].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ophthalmologyscience.org/article/S2666-9145(25)00275-1/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-16T00:00:00 |
| display_name | Structural Biomarkers Influencing Drusenoid Pigment Epithelial Detachment Lifecycle and the Development of Late Macular Degeneration |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-25T14:43:58.451035 |
| primary_topic.id | https://openalex.org/T10170 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Retinal Diseases and Treatments |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.xops.2025.100977 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210240620 |
| best_oa_location.source.issn | 2666-9145 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2666-9145 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Ophthalmology Science |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.ophthalmologyscience.org/article/S2666-9145(25)00275-1/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Ophthalmology Science |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.xops.2025.100977 |
| primary_location.id | doi:10.1016/j.xops.2025.100977 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210240620 |
| primary_location.source.issn | 2666-9145 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2666-9145 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Ophthalmology Science |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | https://www.ophthalmologyscience.org/article/S2666-9145(25)00275-1/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Ophthalmology Science |
| primary_location.landing_page_url | https://doi.org/10.1016/j.xops.2025.100977 |
| publication_date | 2025-10-15 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2058344658, https://openalex.org/W2028849037, https://openalex.org/W1993828795, https://openalex.org/W1996821302, https://openalex.org/W2537146178, https://openalex.org/W2494415462, https://openalex.org/W2795491805, https://openalex.org/W2325214394, https://openalex.org/W2519651412, https://openalex.org/W2038861323, https://openalex.org/W2018824991, https://openalex.org/W2964546533, https://openalex.org/W1899481868, https://openalex.org/W4400926114, https://openalex.org/W2333569680, https://openalex.org/W2804685255, https://openalex.org/W2517716364, https://openalex.org/W4310945468, https://openalex.org/W2807327270, https://openalex.org/W2587098848, https://openalex.org/W2964341697, https://openalex.org/W2997572594, https://openalex.org/W2580718190, https://openalex.org/W2256674952, https://openalex.org/W2004808679, https://openalex.org/W2083220069, https://openalex.org/W2325901584, https://openalex.org/W2988969159, https://openalex.org/W2766820003, https://openalex.org/W2609280032, https://openalex.org/W1964088771, https://openalex.org/W2888323593, https://openalex.org/W4390275015, https://openalex.org/W2093744133, https://openalex.org/W4307713334, https://openalex.org/W3016168001, https://openalex.org/W4387083815, https://openalex.org/W4318757316, https://openalex.org/W2010224573, https://openalex.org/W2765614411, https://openalex.org/W2034474306, https://openalex.org/W2024647444, https://openalex.org/W2047718111, https://openalex.org/W2898549572, https://openalex.org/W3193777758, https://openalex.org/W3085783162, https://openalex.org/W2757415320 |
| referenced_works_count | 47 |
| abstract_inverted_index.= | 258, 275, 302, 308, 316, 322, 332, 338 |
| abstract_inverted_index.A | 50 |
| abstract_inverted_index.P | 257, 274, 307, 321, 337 |
| abstract_inverted_index.a | 7, 144, 226, 294 |
| abstract_inverted_index.51 | 87 |
| abstract_inverted_index.GA | 346 |
| abstract_inverted_index.In | 240, 285 |
| abstract_inverted_index.an | 92 |
| abstract_inverted_index.as | 21, 127 |
| abstract_inverted_index.at | 267, 329, 391 |
| abstract_inverted_index.be | 384 |
| abstract_inverted_index.in | 10, 58, 359, 386 |
| abstract_inverted_index.is | 6 |
| abstract_inverted_index.of | 31, 44, 61, 79, 95, 171, 229, 234, 263, 282, 310, 355, 394 |
| abstract_inverted_index.or | 123, 380 |
| abstract_inverted_index.to | 35, 70, 147, 157, 169, 237 |
| abstract_inverted_index.± | 97 |
| abstract_inverted_index.95% | 252, 271, 304, 318, 334 |
| abstract_inverted_index.CI: | 272, 305, 319, 335 |
| abstract_inverted_index.Cox | 139, 202, 243 |
| abstract_inverted_index.GA) | 176 |
| abstract_inverted_index.GA. | 48 |
| abstract_inverted_index.HRF | 314 |
| abstract_inverted_index.Key | 223 |
| abstract_inverted_index.MNV | 46, 311 |
| abstract_inverted_index.OCT | 68, 182 |
| abstract_inverted_index.RPE | 375 |
| abstract_inverted_index.The | 29, 152 |
| abstract_inverted_index.aim | 30 |
| abstract_inverted_index.and | 25, 47, 75, 115, 133, 167, 175, 177, 193, 205, 217, 260, 324, 369, 374, 389 |
| abstract_inverted_index.end | 393 |
| abstract_inverted_index.for | 149, 159 |
| abstract_inverted_index.may | 365, 383 |
| abstract_inverted_index.the | 42, 59, 72, 241, 261, 278, 286, 352, 387, 392 |
| abstract_inverted_index.via | 105 |
| abstract_inverted_index.was | 34, 155 |
| abstract_inverted_index.(HR: | 269 |
| abstract_inverted_index.(MNV | 174 |
| abstract_inverted_index.(sHR | 315, 331 |
| abstract_inverted_index.17.6 | 98 |
| abstract_inverted_index.3.8, | 251 |
| abstract_inverted_index.37.5 | 96 |
| abstract_inverted_index.6.6, | 270 |
| abstract_inverted_index.AMD. | 62 |
| abstract_inverted_index.Main | 163 |
| abstract_inverted_index.OCT, | 116 |
| abstract_inverted_index.This | 64 |
| abstract_inverted_index.both | 45, 124 |
| abstract_inverted_index.dPED | 57, 73, 85, 212, 230 |
| abstract_inverted_index.eyes | 83 |
| abstract_inverted_index.foci | 265 |
| abstract_inverted_index.from | 86 |
| abstract_inverted_index.help | 370 |
| abstract_inverted_index.into | 17 |
| abstract_inverted_index.main | 279 |
| abstract_inverted_index.over | 91 |
| abstract_inverted_index.risk | 161 |
| abstract_inverted_index.such | 20 |
| abstract_inverted_index.term | 146 |
| abstract_inverted_index.this | 32, 395 |
| abstract_inverted_index.time | 168 |
| abstract_inverted_index.used | 156 |
| abstract_inverted_index.were | 89, 125, 136, 340 |
| abstract_inverted_index.with | 41, 56, 84, 143, 180, 200, 232, 344 |
| abstract_inverted_index.zone | 191 |
| abstract_inverted_index.(GA). | 28 |
| abstract_inverted_index.(HRF) | 266 |
| abstract_inverted_index.(MNV) | 24 |
| abstract_inverted_index.0.01) | 309 |
| abstract_inverted_index.0.02) | 276 |
| abstract_inverted_index.18.1, | 303 |
| abstract_inverted_index.3.69, | 333 |
| abstract_inverted_index.39.4% | 227 |
| abstract_inverted_index.6.69, | 317 |
| abstract_inverted_index.60.7% | 233 |
| abstract_inverted_index.These | 349 |
| abstract_inverted_index.[CI]: | 255 |
| abstract_inverted_index.[HR]: | 250 |
| abstract_inverted_index.[RPE] | 197 |
| abstract_inverted_index.[sHR] | 301 |
| abstract_inverted_index.cases | 235 |
| abstract_inverted_index.color | 110 |
| abstract_inverted_index.dPED. | 360 |
| abstract_inverted_index.early | 364 |
| abstract_inverted_index.foci, | 187 |
| abstract_inverted_index.found | 385 |
| abstract_inverted_index.green | 121 |
| abstract_inverted_index.model | 154 |
| abstract_inverted_index.often | 15 |
| abstract_inverted_index.ratio | 249, 300 |
| abstract_inverted_index.risk. | 347 |
| abstract_inverted_index.risks | 289 |
| abstract_inverted_index.study | 33, 66 |
| abstract_inverted_index.their | 178 |
| abstract_inverted_index.these | 362 |
| abstract_inverted_index.using | 138 |
| abstract_inverted_index.which | 108 |
| abstract_inverted_index.while | 117, 313 |
| abstract_inverted_index.(AMD), | 14 |
| abstract_inverted_index.(dPED) | 5 |
| abstract_inverted_index.0.002) | 259, 323 |
| abstract_inverted_index.0.044) | 339 |
| abstract_inverted_index.assess | 71 |
| abstract_inverted_index.cohort | 52 |
| abstract_inverted_index.drusen | 247, 292 |
| abstract_inverted_index.fundus | 111, 113 |
| abstract_inverted_index.hazard | 141, 299 |
| abstract_inverted_index.model, | 245 |
| abstract_inverted_index.models | 142 |
| abstract_inverted_index.months | 99 |
| abstract_inverted_index.risks; | 208 |
| abstract_inverted_index.study. | 53 |
| abstract_inverted_index.timely | 367 |
| abstract_inverted_index.width, | 220 |
| abstract_inverted_index.(hazard | 248 |
| abstract_inverted_index.(range: | 100 |
| abstract_inverted_index.Design: | 49 |
| abstract_inverted_index.Outcome | 164 |
| abstract_inverted_index.account | 148, 158 |
| abstract_inverted_index.atrophy | 27 |
| abstract_inverted_index.average | 93 |
| abstract_inverted_index.between | 130 |
| abstract_inverted_index.damage. | 376 |
| abstract_inverted_index.drusen, | 185 |
| abstract_inverted_index.factors | 341 |
| abstract_inverted_index.frailty | 145 |
| abstract_inverted_index.hazards | 204 |
| abstract_inverted_index.imaging | 357 |
| abstract_inverted_index.macular | 12, 18, 22, 80, 134, 172, 283 |
| abstract_inverted_index.modeled | 199 |
| abstract_inverted_index.needed. | 128 |
| abstract_inverted_index.notable | 8 |
| abstract_inverted_index.pigment | 2, 195 |
| abstract_inverted_index.prevent | 371 |
| abstract_inverted_index.results | 350 |
| abstract_inverted_index.retinal | 194 |
| abstract_inverted_index.setting | 60 |
| abstract_inverted_index.support | 366 |
| abstract_inverted_index.timing) | 216 |
| abstract_inverted_index.(height, | 219 |
| abstract_inverted_index.Methods: | 63 |
| abstract_inverted_index.Patients | 55 |
| abstract_inverted_index.Purpose: | 0 |
| abstract_inverted_index.Results: | 222 |
| abstract_inverted_index.analyzed | 67 |
| abstract_inverted_index.article. | 396 |
| abstract_inverted_index.assessed | 137 |
| abstract_inverted_index.baseline | 131, 181, 268, 330 |
| abstract_inverted_index.evolving | 16 |
| abstract_inverted_index.external | 188, 325 |
| abstract_inverted_index.features | 77, 214, 363 |
| abstract_inverted_index.findings | 224 |
| abstract_inverted_index.identify | 36, 76 |
| abstract_inverted_index.imaging, | 107 |
| abstract_inverted_index.included | 109, 211, 225 |
| abstract_inverted_index.intereye | 150 |
| abstract_inverted_index.interval | 254 |
| abstract_inverted_index.limiting | 189, 326 |
| abstract_inverted_index.measures | 210 |
| abstract_inverted_index.membrane | 327 |
| abstract_inverted_index.patients | 88 |
| abstract_inverted_index.presence | 262 |
| abstract_inverted_index.remained | 293 |
| abstract_inverted_index.reviewed | 90 |
| abstract_inverted_index.specific | 356 |
| abstract_inverted_index.volume). | 221 |
| abstract_inverted_index.Drusenoid | 1 |
| abstract_inverted_index.Financial | 377 |
| abstract_inverted_index.Footnotes | 388 |
| abstract_inverted_index.Incidence | 166 |
| abstract_inverted_index.Measures: | 165 |
| abstract_inverted_index.analysis, | 290 |
| abstract_inverted_index.analysis. | 162 |
| abstract_inverted_index.collapse, | 231 |
| abstract_inverted_index.competing | 160, 207, 288 |
| abstract_inverted_index.cuticular | 246, 291 |
| abstract_inverted_index.examining | 102 |
| abstract_inverted_index.follow-up | 94 |
| abstract_inverted_index.incidence | 228 |
| abstract_inverted_index.increased | 345 |
| abstract_inverted_index.lifecycle | 74, 213 |
| abstract_inverted_index.performed | 126 |
| abstract_inverted_index.phenotype | 9 |
| abstract_inverted_index.potential | 37 |
| abstract_inverted_index.predictor | 297 |
| abstract_inverted_index.relevance | 354 |
| abstract_inverted_index.secondary | 209 |
| abstract_inverted_index.treatment | 368 |
| abstract_inverted_index.(collapse, | 215 |
| abstract_inverted_index.(cuticular | 184 |
| abstract_inverted_index.1.97–22, | 273 |
| abstract_inverted_index.24–104), | 101 |
| abstract_inverted_index.associated | 40, 343 |
| abstract_inverted_index.biomarkers | 39, 69, 132, 183, 358 |
| abstract_inverted_index.commercial | 381 |
| abstract_inverted_index.confidence | 253 |
| abstract_inverted_index.detachment | 4 |
| abstract_inverted_index.disclosure | 382 |
| abstract_inverted_index.disruption | 328 |
| abstract_inverted_index.epithelial | 3 |
| abstract_inverted_index.epithelium | 196 |
| abstract_inverted_index.geographic | 26 |
| abstract_inverted_index.indicators | 281 |
| abstract_inverted_index.integrity, | 192 |
| abstract_inverted_index.multimodal | 106 |
| abstract_inverted_index.predictive | 78 |
| abstract_inverted_index.prognostic | 38, 280, 353 |
| abstract_inverted_index.structural | 103 |
| abstract_inverted_index.underscore | 351 |
| abstract_inverted_index.1.62–9.2, | 256 |
| abstract_inverted_index.1.89–174, | 306 |
| abstract_inverted_index.Disclosures | 390 |
| abstract_inverted_index.Fine–Gray | 153, 206, 287 |
| abstract_inverted_index.Proprietary | 379 |
| abstract_inverted_index.Recognizing | 361 |
| abstract_inverted_index.Seventy-one | 82 |
| abstract_inverted_index.age-related | 11 |
| abstract_inverted_index.alterations | 104 |
| abstract_inverted_index.development | 43, 170 |
| abstract_inverted_index.fluorescein | 118 |
| abstract_inverted_index.independent | 296 |
| abstract_inverted_index.indocyanine | 120 |
| abstract_inverted_index.progressing | 236 |
| abstract_inverted_index.represented | 277 |
| abstract_inverted_index.significant | 295 |
| abstract_inverted_index.Associations | 129 |
| abstract_inverted_index.Conclusions: | 348 |
| abstract_inverted_index.angiography, | 119, 122 |
| abstract_inverted_index.associations | 179 |
| abstract_inverted_index.correlation. | 151 |
| abstract_inverted_index.degeneration | 13 |
| abstract_inverted_index.development, | 312 |
| abstract_inverted_index.irreversible | 372 |
| abstract_inverted_index.photography, | 112 |
| abstract_inverted_index.proportional | 140, 203, 244 |
| abstract_inverted_index.1.03–13.14, | 336 |
| abstract_inverted_index.1.98–22.61, | 320 |
| abstract_inverted_index.Participants: | 54 |
| abstract_inverted_index.complications | 19, 135, 173, 238 |
| abstract_inverted_index.morphometrics | 218 |
| abstract_inverted_index.multivariable | 242 |
| abstract_inverted_index.observational | 65 |
| abstract_inverted_index.photoreceptor | 373 |
| abstract_inverted_index.postcollapse. | 239 |
| abstract_inverted_index.retrospective | 51 |
| abstract_inverted_index.significantly | 342 |
| abstract_inverted_index.Disclosure(s): | 378 |
| abstract_inverted_index.complications. | 81, 284 |
| abstract_inverted_index.hyperreflective | 186, 264 |
| abstract_inverted_index.(subdistribution | 298 |
| abstract_inverted_index.frailty-adjusted | 201 |
| abstract_inverted_index.autofluorescence, | 114 |
| abstract_inverted_index.membrane/ellipsoid | 190 |
| abstract_inverted_index.neovascularization | 23 |
| abstract_inverted_index.hypertransmission), | 198 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile.value | 0.6663563 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |